SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
11.05
+0.01 (0.09%)
At close: Aug 11, 2026, 4:00 PM EDT
11.06
+0.01 (0.06%)
After-hours: Aug 11, 2026, 7:59 PM EDT
SELLAS Life Sciences Group Employees
SELLAS Life Sciences Group had 13 employees as of December 31, 2025. The number of employees decreased by 2 or -13.33% compared to the previous year.
Employees
13
Change (1Y)
-2
Growth (1Y)
-13.33%
Revenue / Employee
n/a
Profits / Employee
-$2,497,000
Market Cap
2.17B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 13 | -2 | -13.33% |
| Dec 31, 2024 | 15 | -1 | -6.25% |
| Dec 31, 2023 | 16 | -1 | -5.88% |
| Dec 31, 2022 | 17 | 6 | 54.55% |
| Dec 31, 2021 | 11 | 4 | 57.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ADMA Biologics | 647 |
| Vericel | 398 |
| Vera Therapeutics | 339 |
| Ocular Therapeutix | 325 |
| Nuvation Bio | 305 |
| Biohaven | 274 |
| Stoke Therapeutics | 170 |
| Septerna | 130 |
SLS News
- 10 hours ago - SELLAS Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 19 hours ago - SELLAS Life Sciences Group Quarterly report: Q2 2026 - Filings
- 19 hours ago - SELLAS Life Sciences Group Earnings release: Q2 2026 - Filings
- 25 days ago - Sellas Life Sciences rises 11.0% - TheFly
- 25 days ago - Sellas Life Sciences rises 10.2% - TheFly
- 5 weeks ago - Sellas Life Sciences price target raised to $25 from $10 at Alliance Global - TheFly
- 5 weeks ago - Sellas Life Sciences falls -11.0% - TheFly
- 6 weeks ago - Sellas Life Sciences falls -8.9% - TheFly